{
  "prompt": {
    "transcript": "Here’s a fictional but clinically authentic SBAR clerking for a patient with **cervical intraepithelial neoplasia (CIN)**, using British medical terminology and abbreviations:  \n\n---  \n\n### **SBAR CLERKING – CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)**  \n\n#### **SITUATION:**  \n- **Patient:** 32F, G2P1, non-smoker  \n- **Presenting complaint:** Referred to Gynaecology Oncology Clinic following abnormal cervical screening (HPV+ with high-grade dyskaryosis).  \n- **Key issue:** Colposcopy-confirmed **CIN3** (squamo-columnar junction fully visible, satisfactory colposcopy). Asymptomatic, no PV bleeding/discharge.  \n\n#### **BACKGROUND:**  \n- **PMHx:** Previous LLETZ (2019) for CIN2. No other gynae history.  \n- **Obstetric Hx:** SVD 2018 (no complications).  \n- **Medications:** Nil regular. No allergies.  \n- **Risk factors:** Persistent high-risk HPV (type 16 detected), previous CIN.  \n- **Last menstrual period (LMP):** Day 12 of cycle.  \n\n#### **ASSESSMENT:**  \n- **Observations:** Afebrile, BP 118/72, HR 72, BMI 24.  \n- **Examination:** Speculum – healthy cervix, no contact bleeding. No vulval/vaginal lesions.  \n- **Colposcopy findings:** Acetowhite epithelium, coarse mosaicism, punctation at 3 o’clock (TZ3).  \n- **Histology (biopsy):** CIN3 with clear margins. No invasive features.  \n- **Recent investigations:**  \n  - **HPV PCR:** Positive (type 16).  \n  - **FBC:** Normal (Hb 132, WBC 6.2, Plt 280).  \n  - **USS pelvis:** Normal uterus/adnexa.  \n\n#### **RECOMMENDATION:**  \n1. **Treatment:**  \n   - **LLETZ excision** under local anaesthesia (GA if anxious) – booked for next available list.  \n   - Consent for possible future preterm labour risk (cervical weakness).  \n\n2. **Follow-up:**  \n   - **Post-op HPV test at 6 months** (if negative, return to routine screening; if positive, repeat colposcopy).  \n   - **Annual cytology x3 years** if margins unclear on histology.  \n\n3. **Patient counselling:**  \n   - Reinforce HPV vaccination (if not already received).  \n   - Advise barrier contraception to reduce HPV transmission risk.  \n   - Safety-netting: Report PV bleeding/pelvic pain.  \n\n4. **MDT referral:**  \n   - Discuss in **Gynae-Oncology MDT** if any suspicion of microinvasion on histology.  \n\n---  \n\n**Notes:**  \n- Follows **BSCCP/British Gynaecological Cancer Society** guidelines.  \n- Fictional for educational purposes.  \n\nWould you like any modifications (e.g., more detail on histology, MDT criteria, or patient counselling points)?",
    "guidelinesCount": 266,
    "chunksProcessed": 34,
    "chunksFailed": 0
  },
  "response": "{\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 2,\n  \"potentiallyRelevantCount\": 10,\n  \"lessRelevantCount\": 38,\n  \"notRelevantCount\": 216\n}",
  "endpoint": "findRelevantGuidelines",
  "timestamp": "2025-07-12T14-55-32",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"transcript\": \"Here’s a fictional but clinically authentic SBAR clerking for a patient with **cervical intraepithelial neoplasia (CIN)**, using British medical terminology and abbreviations:  \\n\\n---  \\n\\n### **SBAR CLERKING – CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)**  \\n\\n#### **SITUATION:**  \\n- **Patient:** 32F, G2P1, non-smoker  \\n- **Presenting complaint:** Referred to Gynaecology Oncology Clinic following abnormal cervical screening (HPV+ with high-grade dyskaryosis).  \\n- **Key issue:** Colposcopy-confirmed **CIN3** (squamo-columnar junction fully visible, satisfactory colposcopy). Asymptomatic, no PV bleeding/discharge.  \\n\\n#### **BACKGROUND:**  \\n- **PMHx:** Previous LLETZ (2019) for CIN2. No other gynae history.  \\n- **Obstetric Hx:** SVD 2018 (no complications).  \\n- **Medications:** Nil regular. No allergies.  \\n- **Risk factors:** Persistent high-risk HPV (type 16 detected), previous CIN.  \\n- **Last menstrual period (LMP):** Day 12 of cycle.  \\n\\n#### **ASSESSMENT:**  \\n- **Observations:** Afebrile, BP 118/72, HR 72, BMI 24.  \\n- **Examination:** Speculum – healthy cervix, no contact bleeding. No vulval/vaginal lesions.  \\n- **Colposcopy findings:** Acetowhite epithelium, coarse mosaicism, punctation at 3 o’clock (TZ3).  \\n- **Histology (biopsy):** CIN3 with clear margins. No invasive features.  \\n- **Recent investigations:**  \\n  - **HPV PCR:** Positive (type 16).  \\n  - **FBC:** Normal (Hb 132, WBC 6.2, Plt 280).  \\n  - **USS pelvis:** Normal uterus/adnexa.  \\n\\n#### **RECOMMENDATION:**  \\n1. **Treatment:**  \\n   - **LLETZ excision** under local anaesthesia (GA if anxious) – booked for next available list.  \\n   - Consent for possible future preterm labour risk (cervical weakness).  \\n\\n2. **Follow-up:**  \\n   - **Post-op HPV test at 6 months** (if negative, return to routine screening; if positive, repeat colposcopy).  \\n   - **Annual cytology x3 years** if margins unclear on histology.  \\n\\n3. **Patient counselling:**  \\n   - Reinforce HPV vaccination (if not already received).  \\n   - Advise barrier contraception to reduce HPV transmission risk.  \\n   - Safety-netting: Report PV bleeding/pelvic pain.  \\n\\n4. **MDT referral:**  \\n   - Discuss in **Gynae-Oncology MDT** if any suspicion of microinvasion on histology.  \\n\\n---  \\n\\n**Notes:**  \\n- Follows **BSCCP/British Gynaecological Cancer Society** guidelines.  \\n- Fictional for educational purposes.  \\n\\nWould you like any modifications (e.g., more detail on histology, MDT criteria, or patient counselling points)?\",\n  \"guidelinesCount\": 266,\n  \"chunksProcessed\": 34,\n  \"chunksFailed\": 0\n}\n\nA: {\n  \"success\": true,\n  \"categoriesFound\": 266,\n  \"mostRelevantCount\": 2,\n  \"potentiallyRelevantCount\": 10,\n  \"lessRelevantCount\": 38,\n  \"notRelevantCount\": 216\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}